MPower Maryland | In the Press

4th Annual ALEI Conference Continues to Serve Farmers

Published 11/28/18 on UMB News

If there is one takeaway from this morning’s panels,” said Donald Tobin, JD, dean...

Seed Grant Kick Starts Innovative Research Through Complementary Connections

Published 11/29/18 on UMB News Daniel Mullins, PhD, works for the University of Maryland, Baltimore(UMB) and is a professor and...

NIH funds quest for next generation of HIV agents

In the Press No Comments

Published 11/28/18 on UMB News

Researchers at the Institute for Bioscience and Biotechnology...

Maryland researchers receive $3.9M from NIH to develop new HIV treatment

In the Press No Comments

Posted 11/21/18 on Technical.ly Baltimore

The work at the University of Maryland aims to contribute to treatments that could lead to "HIV remission and possible...

IBBR investigator to lead $3.9M NIH-funded project to develop next generation HIV-1 immunotherapy agents

In the Press No Comments

Submitted by Timna Wyckoff on November 20, 2018 - 10:15

U Maryland-Baltimore licenses lung injury treatment to GEn1E Lifesciences

In the Press No Comments

Published 10/24/18 on Tech Transfer eNews Blog Preclinical stage drug developer GEn1E Lifesciences has entered into a license agreement with the University of Maryland-Baltimore (UMB) to...

SAFE Center Awarded $843K to Expand Mental Health, Emergency Crisis Services

In the Press No Comments

Published 10/22/18 in Maryland Today The University of Maryland SAFE Center for Human Trafficking Survivors has been awarded a $843,337 grant from the Maryland Governor’s Office of Crime Control...

From pain to memory, researchers investigate how VR can make things go better in the real world

In the Press No Comments

Published on GeekWire, 10/22/18
Freelance science writer Berly McCoy uses a...

GEn1E Lifesciences Granted Exclusive Option to License University of Maryland, Baltimore’s Selective P38 Kinase Inhibitor

In the Press No Comments

Published 10/17/18 by GEn1E Lifesciences, Inc.
Access to University of Maryland, Baltimore’s broadly applicable P38 Kinase inhibitor technology offers GEn1E the potential to enter the clinic...

UMB startup developing artificial lung raising up to $5 million

In the Press No Comments

Published 10/8/18 in the Baltimore Business Journal
University of Maryland, Baltimore-born startup Breethe Inc. is looking to raise about $5 million in...

Pages 1 of 22 :

1
2
3
4
5
6
7
Last

© 2014-2015 MPower Maryland, All Rights Reserved.